SCHEMBL23937935

SCHEMBL23937935

COc1ncnc2sccc12

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 6/20 0.71
LMNA P02545 2/20 0.71
ALDH1A1 P00352 3/20 0.61
MRGPRX1 Q96LB2 2/20 0.59
CYP1A2 P05177 1/20 0.59
CYP2C19 P33261 1/20 0.59
SMN1; SMN2 Q16637 3/20 0.55
NPC1 O15118 4/20 0.54
CHEK1 O14757 1/20 0.53
AURKA O14965 1/20 0.53
DAPK3 O43293 1/20 0.53
JAK2 O60674 1/20 0.53
MAP4K4 O95819 1/20 0.53
ABL1 P00519 1/20 0.53
NTRK1 P04629 1/20 0.53
LCK P06239 1/20 0.53
FYN P06241 1/20 0.53
CSF1R P07333 1/20 0.53
RET P07949 1/20 0.53
IGF1R P08069 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26978589 0.76 ALDH1A1 (1.00) RAB9ALMNAALDH1A1MRGPRX1CYP1A2
SCHEMBL3977779 0.75 ALDH1A1 (0.72) RAB9ALMNAALDH1A1MRGPRX1CYP1A2
SCHEMBL26980580 0.75 MRGPRX1 (1.00) RAB9ALMNAALDH1A1MRGPRX1CYP1A2
SCHEMBL29689504 0.74 MRGPRX1 (1.00) RAB9ALMNAALDH1A1MRGPRX1CYP1A2
SCHEMBL8018832 0.74 CHEK1 (0.59) RAB9ALMNAALDH1A1MRGPRX1CYP1A2
SCHEMBL29186533 0.73 RAB9A (0.64) RAB9ALMNAALDH1A1MRGPRX1CYP1A2
SCHEMBL29317895 0.72 RAB9A (0.63) RAB9ALMNAALDH1A1MRGPRX1CYP1A2
SCHEMBL23599113 0.72 KMT2A (0.44) RAB9ALMNAALDH1A1MRGPRX1CYP1A2
SCHEMBL2843606 0.71 CHEK1 (0.61) RAB9ALMNAALDH1A1MRGPRX1CYP1A2
SCHEMBL12559905 0.69 CHEK1 (0.59) RAB9ALMNAALDH1A1MRGPRX1CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3399968-B1 SELECTIVE INHIBITORS OF CLINICALLY IMPORTANT MUTANTS OF THE EGFR TYROSINE KINASE CS PHARMATECH LTD (KY) 2021-10-20 EP disclosed